ILLUMINA, INC.ILMNEarnings & Financial Report
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
ILMN Q4 2025 Key Financial Metrics
营收
$1.1B
毛利润
$728.0M
营业利润
$174.0M
净利润
$186.0M
毛利率
65.9%
营业利润率
15.8%
净利率
16.8%
同比增长
-1.6%
EPS
$1.16
资金流向
ILLUMINA, INC. Q4 2025 Financial Summary
ILLUMINA, INC. reported revenue of $1.1B (down 1.6% YoY) for Q4 2025, with a net profit of $186.0M (up 205.7% YoY) (16.8% margin). Cost of goods sold was $376.0M, operating expenses totaled $554.0M.
Key Financial Metrics
| Total Revenue | $1.1B |
|---|---|
| Net Profit | $186.0M |
| Gross Margin | 65.9% |
| Operating Margin | 15.8% |
| Report Period | Q4 2025 |
Revenue Breakdown
ILLUMINA, INC. Q4 2025 revenue of $1.1B breaks down across 3 segments, led by Sequencing at $1.0B (90.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Sequencing | $1.0B | 90.9% |
| Microarray | $101.0M | 9.1% |
| Investee | $7.0M | 0.6% |
ILLUMINA, INC. Revenue by Segment — Quarterly Trend
ILLUMINA, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Sequencing and Microarray) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Sequencing | $1.0B | $995.0M | — | — |
| Microarray | $101.0M | $85.0M | — | $97.0M |
| Investee | $7.0M | $7.0M | $4.0M | $2.0M |
ILLUMINA, INC. Annual Revenue by Year
ILLUMINA, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.4B). Click any linked year to see what changed vs the prior 10-K.
ILLUMINA, INC. Quarterly Revenue & Net Profit History
ILLUMINA, INC. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $1.1B | -1.6% | $186.0M | 16.8% |
| Q3 2025 | $1.1B | -3.5% | $705.0M | 65.3% |
| Q2 2025 | $1.1B | -5.4% | $-2.0B | -178.8% |
| Q1 2025 | $1.1B | -1.0% | $-126.0M | -11.7% |
| Q4 2024 | $1.1B | +3.5% | $-176.0M | -15.7% |
| Q3 2024 | $1.1B | +0.4% | $-754.0M | -67.4% |
| Q2 2024 | $1.2B | +1.2% | $-234.0M | -19.9% |
| Q1 2024 | $1.1B | -11.1% | $3.0M | 0.3% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $1.09B | $1.18B | $1.12B | $1.12B | $1.08B | $1.11B | $1.08B | $1.10B |
| 同比增长 | -11.1% | 1.2% | 0.4% | 3.5% | -1.0% | -5.4% | -3.5% | -1.6% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $11.81B | $11.77B | $10.12B | $10.11B | $10.04B | $6.08B | $6.01B | $6.30B |
| 总负债 | $5.12B | $5.22B | $4.22B | $4.37B | $4.31B | $4.64B | $3.89B | $3.93B |
| 股东权益 | $6.69B | $6.55B | $5.90B | $5.75B | $5.73B | $1.44B | $2.13B | $2.37B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $10.0M | $105.0M | $139.0M | $224.0M | $77.0M | $80.0M | $316.0M | $364.0M |